Fulminant meningococcal sepsis: Localized outbreak of three patients treated with therapeutic plasma exchange by membrane filtration

Blood Purification

Volumn 30, Issue 2, 2010, Pages 108-110

  Patel, Pritesh ^a   Bangalore, Vinay G ^a   Cantwell, William S ^a   Troxclair, Sean ^a   Scott, Keith L ^a   Conrad, Steven ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; BLOOD CLOTTING DISORDER; BLOOD CULTURE; CASE REPORT; CHILD; CLINICAL FEATURE; CONTINUOUS HEMOFILTRATION; FEMALE; HOLLOW FIBER; HUMAN; LETTER; MALE; MEMBRANE FILTER; MENINGOCOCCEMIA; MORTALITY; NEISSERIA MENINGITIDIS; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADOLESCENT; CHILD, PRESCHOOL; FEMALE; HEMOFILTRATION; HUMANS; MALE; MENINGOCOCCAL INFECTIONS; PLASMA EXCHANGE; SEPSIS; YOUNG ADULT;

EID: 77955109160     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319702     Document Type: Letter

References (20)

1. Munford RS: Sepsis, severe sepsis, and septic shock; in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, ed 6. New York, Elsevier-Churchill, Livingstone, 2005, pp 907-926.
2. Apicella MA: Neisseria meningitides; in Mandell GL, Bennett JE, Dolin R (eds): Prin-ciples and Practice of Infectious Diseases, ed 6. Elsevier-Churchill, Livingstone, 2005, pp 2498-2513.
3. CDC: Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005; 54:1-21.
4. CDC: Summary of notifiable diseases, United States 2007. MMWR 2007; 56: 794-795.
5. McManus ML, Churchwell KB: Coagulopa-thy as a predictor of outcome in meningo-coccal sepsis and the systemic inflammatory response syndrome with purpura. Crit Care Med 1993; 21:706-711.
6. Brandtzaeg P, Kerrulf P, Gaustad P: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204.
7. Brandtzaeg P, Mollnes TE, Kierulf P: Com-plement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 1989; 160: 58-65.
8. Brandtzaeg P, Joo GB, Brusletto B: Plasmino-gen activator inhibitor 1 and 2, ct2-antiplas-min, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990; 57: 271-278.
9. Brandtzaeg P, Sandset PM, Joo GB: The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989; 55:459-470.
10. Iwai H, Nagaki M, NaitoT, Ishiki Y, Murakami N, Sugihara J, Muto Y, Moriwaki H: Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998; 26: 873-876.
11. Churchwell KB, McManus ML, Kent P, Gor-lin J, Galacki D, Humphreys D, Kevy SV: Intensive blood and plasma exchange for treat-ment of coagulopathy in meningococcemia. J Clin Apher 1995; 10:171-177.
12. Van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW: Plasma and whole blood exchange in menin-gococcal sepsis. Clin Infect Dis 1992; 15:424-430.
13. Pollack MM, Ruttimann UE, Getson PR: Pe-diatric risk of mortality (PRISM) score. Crit Care Med 1988; 16: 1110-1116.
14. Pollack MM, Patel KM, Ruttimann UE: PRISM III: an updated pediatric risk of mor-tality score. Crit Care Med 1996; 24:743-752.
15. Sinclair JF, Skeoch CH, Hallworth D: Prog-nosis of meningococcal septicaemia. Lancet 1987;ii:38. (Pubitemid 17083679)
16. Castellanos-Ortega A, Delgado-Rodriguez M: Comparison of the performance of two general and three specific scoring systems for meningococcal septic shock in children. Crit Care Med 2000; 28: 2967-2973.
17. Leteurtre S, Leclerc F, Martinot A: Can ge-neric scores (Pediatric Risk of Mortality and Pediatric Index of Mortality) replace specific scores in predicting the outcome of pre-sumed meningococcal septic shock in chil-dren? Crit Care Med 2001; 29: 1239-1246.
18. Derkx B, Wittes J, McCloskey R: Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis 1999; 28:770-777.
19. 21) as adjunctive treatment for children with severe meningococcal sepsis: a randomized trial. Lancet 2000; 356: 961-967.
20. Drapkin MS, Wisch JS, Gelfland JA: Plasma-pheresis for fulminant meningococcemia. Pediatr Infect Dis J 1989; 8: 399-400.